Core Viewpoint - Brain动极光 (06681) has seen a significant stock price increase of over 50%, reaching a new high of 9.47 HKD following its inclusion in the Hong Kong Stock Connect program, effective September 8, 2025 [1] Financial Performance - For the first half of 2025, the company reported revenue of 100 million HKD, representing a year-on-year increase of 92.82% [1] Product Development and Innovation - The company has made substantial progress in research and clinical trials for its core pipeline, achieving commercialization for eight indications across four major types of cognitive disorders [1] - The company is also advancing AI innovations in the medical field, with its self-developed medical large model, BrainAuGPT, receiving a national invention patent for a novel training task combination method based on GBR second-order knowledge expression [1]
港股异动 | 脑动极光(06681)涨超50%创新高 近期获纳入港股通名单 核心管线取得重大进展